All In Biotech

Drug Trial Radar · NCT07285798

A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism Spectrum Disorder

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of KarXT + KarX-EC in Children and Adolescents (5 to 17 Years of Age) With Irritability Associated With Autism Spectrum Disorder

Last checked: Nov 19, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 176 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

176

Planned (sponsor's estimate)

Start

Oct 6, 2026

Primary completion

Aug 6, 2029

Study completion Aug 6, 2029

Sponsor

Lead sponsor
Bristol-Myers SquibbBristol Myers Squibb (BMY)
Sponsor type
Industry
First posted
Dec 16, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 5 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess KarXT + KarX-EC for the treatment of irritability associated with autism in children and adolescents.

Conditions

  • Irritability Associated With Autism Spectrum Disorder

Interventions

  • KarXTDrug

    Specified dose on specified days

  • KarX-ECDrug

    Specified dose on specified days

  • KarXT + KarX-EC Matching PlaceboDrug

    Specified dose on specified days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in the Aberrant Behavior Checklist Irritability (ABC-I) Score at Week 8Time frame: Week 8

Locations

67 sites in 10 countries. Site status is shown where the registry gives one.

  • Local Institution - 0062

    Phoenix, Arizona · Not yet recruiting

  • Cortica - Glendale

    Glendale, California · Recruiting

  • Local Institution - 0117

    Los Angeles, California · Not yet recruiting

  • Local Institution - 0126

    Orange, California · Not yet recruiting

  • Local Institution - 0132

    San Diego, California · Not yet recruiting

  • Local Institution - 0115

    San Juan Capistrano, California · Not yet recruiting

  • Cortica - Marin

    San Rafael, California · Recruiting

  • Local Institution - 0130

    New Haven, Connecticut · Not yet recruiting

  • Local Institution - 0048

    Gainesville, Florida · Not yet recruiting

  • Local Institution - 0080

    Orlando, Florida · Not yet recruiting

  • Local Institution - 0072

    Decatur, Georgia · Not yet recruiting

  • EmVenio Research - Chicago

    Chicago, Illinois · Recruiting

  • Local Institution - 0026

    Chicago, Illinois · Withdrawn

  • Local Institution - 0051

    Lexington, Massachusetts · Not yet recruiting

  • Local Institution - 0140

    Bloomfield Hills, Michigan · Not yet recruiting

  • Local Institution - 0016

    Columbia, Missouri · Not yet recruiting

  • Local Institution - 0036

    Saint Charles, Missouri · Not yet recruiting

  • Local Institution - 0046

    Lincoln, Nebraska · Not yet recruiting

  • Local Institution - 0114

    Neptune City, New Jersey · Not yet recruiting

  • Local Institution - 0038

    Staten Island, New York · Not yet recruiting

  • Local Institution - 0052

    Cincinnati, Ohio · Not yet recruiting

  • Local Institution - 0003

    Pittsburgh, Pennsylvania · Not yet recruiting

  • Local Institution - 0125

    Spring, Texas · Not yet recruiting

  • Local Institution - 0009

    Orem, Utah · Not yet recruiting

  • Local Institution - 0019

    Everett, Washington · Not yet recruiting

  • Local Institution - 0088

    Bordeaux, France · Withdrawn

  • Local Institution - 0102

    Bron, France · Not yet recruiting

  • Local Institution - 0089

    Paris, France · Not yet recruiting

  • Local Institution - 0103

    Gdansk, Germany · Not yet recruiting

  • Local Institution - 0111

    Budapest, Hungary · Withdrawn

  • Local Institution - 0127

    Budapest, Hungary · Not yet recruiting

  • Local Institution - 0110

    Szeged, Hungary · Not yet recruiting

  • Local Institution - 0099

    Nagpur, India · Not yet recruiting

  • Local Institution - 0137

    New Delhi, India · Not yet recruiting

  • Local Institution - 0096

    Kozhikode, Kerala, India · Not yet recruiting

  • Local Institution - 0136

    Nashik, Maharashtra, India · Not yet recruiting

  • Local Institution - 0139

    Pune, Maharashtra, India · Not yet recruiting

  • Local Institution - 0101

    Sakri, Maharashtra, India · Not yet recruiting

  • Local Institution - 0138

    Kanpur, Uttar Pradesh, India · Not yet recruiting

  • Local Institution - 0093

    Yokohama, Kanagawa, Japan · Not yet recruiting

Showing 40 of 67 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.